Multidisciplinary treatment approach of Morquio syndrome (mucopolysaccharidosis type IVA)

被引:1
|
作者
Önçag, G
Erdinç, AME
Cal, E
机构
[1] Univ Ege, Dept Orthodont, Fac Dent, TR-35100 Izmir, Turkey
[2] Univ Ege, Dept Prosthodont, Fac Dent, TR-35100 Izmir, Turkey
关键词
multidisciplinary treatment; Morquio syndrome;
D O I
暂无
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Morquio syndrome (mucopolysaccharidosis type IVA) is an autosomal recessive disorder caused by the accumulation of mucopolysaccharides in lysosomes because of the deficiency of N-acetylgalactosamine-6-sulphate sulphatase. Patients with Morquio syndrome often need orthodontic treatment. This study demonstrates the correction of malocclusion by orthodontic treatment and the improvement of the masticatory function by prosthodontic treatment in a male patient affected by Morquio syndrome. Labial inclinations of mandibular and maxillary anterior teeth were corrected, and spaces necessary for prosthodontic restorations were preserved. After this procedure, the restorations were made, and Hawley appliances were used in both jaws for retention. Patient satisfaction and an acceptable occlusal relationship were achieved by following an optimal treatment plan when considering the general status of the patient with Morquio syndrome.
引用
收藏
页码:335 / 340
页数:6
相关论文
共 50 条
  • [21] Airway stenting in MPS IVA (Morquio syndrome type A)
    Yeo, Mildrid
    Korenev, Sergei
    Hewitt, Richard
    Roebuck, Derek
    Cleary, Maureen
    Chakrapani, Anupam
    MOLECULAR GENETICS AND METABOLISM, 2019, 126 (02) : S156 - S156
  • [22] Cervical Disorders in Mucopolysaccharidosis IVA-Morquio disease
    Demartini Jr, Zeferino
    Guimaraes, Ricardo Munhoz da Rocha
    Cardoso-Demartini, Adriane A.
    WORLD NEUROSURGERY, 2021, 153 : 41 - 43
  • [23] THE MORQUIO-A SYNDROME (MUCOPOLYSACCHARIDOSIS IVA) GENE MAPS TO 16Q24.3
    BAKER, E
    GUO, XH
    ORSBORN, AM
    SUTHERLAND, GR
    CALLEN, DF
    HOPWOOD, JJ
    MORRIS, CP
    AMERICAN JOURNAL OF HUMAN GENETICS, 1993, 52 (01) : 96 - 98
  • [24] A MULTICENTER, MULTINATIONAL, LONGITUDINAL CLINICAL ASSESSMENT STUDY OF SUBJECTS WITH MUCOPOLYSACCHARIDOSIS IVA (MORQUIO SYNDROME)
    Harmatz, P.
    Chang, M.
    Decker, C.
    Burton, B.
    Guffon, N.
    Hendriksz, C.
    Hollak, C.
    Jones, S.
    Lin, S.
    Mengel, E.
    Mitchell, J.
    Parini, R.
    Valayannopoulos, V.
    Vellodi, A.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2010, 33 : S143 - S143
  • [25] Enzyme Replacement Therapy with Elosulfase alfa for Mucopolysaccharidosis IVA (Morquio A Syndrome): Milestones and Challenges
    Puckett, Yana
    Mulinder, Holly
    Montano, Adriana M.
    EXPERT OPINION ON ORPHAN DRUGS, 2017, 5 (09): : 741 - 752
  • [26] Molecular basis of mucopolysaccharidosis type IVA (Morquio syndrome type A): A review and classification of GALNS gene variants and reporting of new variants
    Singh, Akashdeep
    Zanetti, Alessandra
    Morrone, Amelia
    Al-Sayed, Moeenaldeen
    Brusius-Facchin, Ana Carolina
    Chien, Yin-Hsiu
    D'Avanzo, Francesca
    Giugliani, Roberto
    Izzo, Emanuela
    Kasper, David C.
    Lin, Hsiang-Yu
    Lin, Shuan-Pei
    Pollard, Laura
    Tonin, Rodolfo
    Wood, Tim
    Tomanin, Rosella
    MOLECULAR GENETICS AND METABOLISM, 2021, 132 (02) : S101 - S101
  • [27] Generation of a rat model of Mucopolysaccharidosis type IVA (Morquio A disease) that reproduces the human pathology
    Bertolin, J.
    Pujol, A.
    Garcia, M.
    Sanchez, V.
    Ribera, A.
    Jaen, M. L.
    Munoz, S.
    Sanchez, X.
    Marco, S.
    Perez, J.
    Elias, G.
    Navarro, M.
    Ruberte, J.
    Bosch, F.
    HUMAN GENE THERAPY, 2019, 30 (11) : A158 - A158
  • [28] Mucopolysaccharidosis IVA (Morquio A syndrome) and VI (Maroteaux–Lamy syndrome): under-recognized and challenging to diagnose
    Ralph S. Lachman
    Barbara K. Burton
    Lorne A. Clarke
    Scott Hoffinger
    Shiro Ikegawa
    Dong-Kyu Jin
    Hiroki Kano
    Ok-Hwa Kim
    Christina Lampe
    Nancy J. Mendelsohn
    Renée Shediac
    Pranoot Tanpaiboon
    Klane K. White
    Skeletal Radiology, 2014, 43 : 359 - 369
  • [29] Intelligence impairment in Morquio syndrome type IVA: A case report
    Indawati, W.
    Sjarif, D. R.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2006, 29 : 149 - 149
  • [30] BMN 110 (Recombinant Human GALNS), an Investigational Enzyme Replacement Therapy for Mucopolysaccharidosis Type IVA (MPS IVA Or Morquio Syndrome), Promotes Type II Collagen Synthesis in MPS IVA Patients
    Lorget, Florence
    Lee, Sungwook
    Lau, Kelly
    Tsuruda, Laurie
    Hendriksz, Chris
    Jones, Simon
    Vellodi, Ashok
    Cheng, Sabrina
    Decker, Celeste
    O'Neill, Charles
    MOLECULAR GENETICS AND METABOLISM, 2012, 105 (02) : S44 - S44